All centres | DGH gastroenterology (%) | DGH hepatology interest (%) | Specialist hepatology (%) | Liver transplant units (%) | |
---|---|---|---|---|---|
Response | |||||
Completed | 116 (66) | 19 (63) | 34 (68) | 48 (72) | 15 (54) |
Incomplete | 59 (34) | 11 (37) | 16 (32) | 19 (28) | 13 (46) |
Local NAFLD guidelines | |||||
Yes | 38 (22) | 1 (3) | 4 (8) | 23 (34) | 10 (35) |
No* | 137 (78) | 29 (97) | 46 (92) | 44 (66) | 18 (65) |
NAFLD fibrosis score | |||||
Performed in all | 48 (41) | 4 (21) | 14 (41) | 22 (46) | 8 (53) |
Selected cases | 29 (25) | 4 (21) | 12 (35) | 10 (21) | 3 (20) |
Not routine* | 39 (34) | 11 (58) | 8 (24) | 16 (33) | 4 (27) |
APRI score | |||||
Performed in all | 8 (6) | 0 (0) | 3 (9) | 2 (4) | 3 (20) |
Selected cases | 18 (16) | 1 (5) | 6 (18) | 10 (21) | 1 (7) |
Not routine* | 90 (78) | 18 (95) | 25 (73) | 36 (75) | 11 (73) |
FIB-4 | |||||
Performed in all | 19 (16) | 1 (5) | 3 (9) | 9 (19) | 6 (40) |
Selected cases | 15 (13) | 1 (5) | 2 (6) | 10 (21) | 2 (13) |
Not routine* | 82 (71) | 17 (90) | 29 (85) | 29 (60) | 7 (47) |
Fibroscan | |||||
Performed in all | 58 (50) | 3 (16) | 11 (32) | 34 (71) | 10 (67) |
Selected cases | 46 (40) | 12 (63) | 17 (50) | 12 (25) | 5 (33) |
Not routine* | 12 (10) | 4 (21) | 6 (18) | 2 (4) | 0 (0) |
AST/ALT ratio | |||||
Performed in all | 62 (53) | 9 (47) | 16 (47) | 28 (58) | 9 (60) |
Selected cases | 24 (21) | 4 (21) | 8 (24) | 10 (21) | 2 (13) |
Not routine* | 30 (26) | 6 (32) | 10 (29) | 10 (21) | 4 (27) |
Liver biopsy | |||||
Performed in all | 7 (6) | 3 (16) | 0 (0) | 2 (4) | 2 (13) |
Selected cases | 90 (78) | 12 (63) | 22 (65) | 43 (90) | 13 (87) |
Not routine* | 19 (16) | 4 (21) | 12 (35) | 3 (6) | 0 (0) |
ELF test | |||||
Performed in all | 6 (5) | 0 (0) | 1 (3) | 0 (0) | 5 (33) |
Selected cases | 10 (9) | 2 (11) | 1 (3) | 4 (8) | 3 (20) |
Not routine* | 100 (86) | 17 (89) | 32 (94) | 44 (92) | 7 (47) |
*Missing responses in completed questionnaires counted as ‘not routine’.
APRI, AST to Platelet Ratio Index; DGH, district general hospital; ELF, Enhanced Liver Fibrosis; NAFLD, non-alcoholic fatty liver disease.